140 related articles for article (PubMed ID: 10362232)
1. The effect of hormone replacement therapy on the sensitivity of screening mammograms.
Litherland JC; Stallard S; Hole D; Cordiner C
Clin Radiol; 1999 May; 54(5):285-8. PubMed ID: 10362232
[TBL] [Abstract][Full Text] [Related]
2. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and mammographic screening.
Evans A
Clin Radiol; 2002 Jul; 57(7):563-4. PubMed ID: 12096852
[TBL] [Abstract][Full Text] [Related]
4. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme.
Litherland JC; Evans AJ; Wilson AR
Clin Radiol; 1997 Apr; 52(4):276-9. PubMed ID: 9112944
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method.
Roubidoux MA; Wilson TE; Orange RJ; Fitzgerald JT; Helvie MA; Packer SA
Radiology; 1998 Sep; 208(3):725-8. PubMed ID: 9722852
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
Crouchley K; Wylie E; Khong E
J Med Screen; 2006; 13(2):93-7. PubMed ID: 16792833
[TBL] [Abstract][Full Text] [Related]
8. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
9. [THE EFFECTS OF HORMONAL REPLACEMENT THERAPY (HRT) ON MAMMOGRAPHIC BREAST DENSITY AND ABNORMAL MAMMOGRAMS PROMPTING FURTHER INVESTIGATION].
Barda L; Nevler A; Rosin D; Shabtai EL; Gutman M; Shabtai M
Harefuah; 2019 Apr; 158(4):239-243. PubMed ID: 31032556
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and accuracy of mammographic screening.
Kavanagh AM; Mitchell H; Giles GG
Lancet; 2000 Jan; 355(9200):270-4. PubMed ID: 10675074
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review.
Banks E
J Med Screen; 2001; 8(1):29-34. PubMed ID: 11373847
[TBL] [Abstract][Full Text] [Related]
12. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
13. Mammographic density in women on postmenopausal hormone replacement therapy.
Leung W; Goldberg F; Zee B; Sterns E
Surgery; 1997 Oct; 122(4):669-73; discussion 673-4. PubMed ID: 9347841
[TBL] [Abstract][Full Text] [Related]
14. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
Carney PA; Miglioretti DL; Yankaskas BC; Kerlikowske K; Rosenberg R; Rutter CM; Geller BM; Abraham LA; Taplin SH; Dignan M; Cutter G; Ballard-Barbash R
Ann Intern Med; 2003 Feb; 138(3):168-75. PubMed ID: 12558355
[TBL] [Abstract][Full Text] [Related]
15. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
16. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
Hofvind S; Møller B; Thoresen S; Ursin G
Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme.
Séradour B; Estève J; Heid P; Jacquemier J
J Med Screen; 1999; 6(2):99-102. PubMed ID: 10444729
[TBL] [Abstract][Full Text] [Related]
19. Missed and true interval and screen-detected breast cancers in a population based screening program.
Hoff SR; Samset JH; Abrahamsen AL; Vigeland E; Klepp O; Hofvind S
Acad Radiol; 2011 Apr; 18(4):454-60. PubMed ID: 21216632
[TBL] [Abstract][Full Text] [Related]
20. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
Sterns EE; Zee B
Breast Cancer Res Treat; 2000 Jan; 59(2):125-32. PubMed ID: 10817347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
